Tris Pharma, Inc.

Quick facts

Marketed products

• Amphetamine Extended Release Suspension [Dyanavel]

Phase 3 pipeline

• TRI102 · Depression
  TRI102 is a medication that works by inhibiting the reuptake of serotonin and norepinephrine.

Phase 2 pipeline

• Cebranopadol 100 µg
• Cebranopadol 300 µg
• Cebranopadol 600 µg · Pain management
  Cebranopadol is a kappa opioid receptor agonist and mu opioid receptor agonist.
• GRT6005 · Gastrointestinal
  GRT6005 is a small molecule drug that targets the serotonin receptor.
• Medium Dose GRT6005
• MS Continus®

Phase 1 pipeline

• Cebranopadol 100 micrograms
• Cebranopadol 1000 µg
• Cebranopadol 400 micrograms
• Cebranopadol 800 µg
• Hydromorphone hydrochloride 4 milligrams
• Qualification · Other
• Tramadol 600 mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tris Pharma, Inc. portfolio CI brief
• Tris Pharma, Inc. pipeline updates RSS